Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective study

Background: Cough is a major symptom of asthma and is associated with poor clinical outcomes. However, current guidelines place little emphasis on the crucial relevance of the cough symptom and its treatment. The objective of this study was to assess the impact of dupilumab on chronic cough (CC) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlo Lombardi, Alvise Berti, Francesco Menzella, Marcello Cottini
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2025-08-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/dupilumab-reduces-patient-reported-cough-and-improves-quality-of-life-in-patients-with-severe-eosinophilic-asthma-with-or-without-chronic-rhinosinusitis-with-nasal-polyps-a-real-life-prospective-study/
Tags: Add Tag
No Tags, Be the first to tag this record!